MedTrace Logo

Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases

NCT02319252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-04-20

No results posted yet for this study

Summary

The study is an unblinded randomized trial, designed to examine whether gastric- or jejunal feeding tubes are the most effect full to feed patients with alcoholic liver diseases and non-sufficient oral intake.

The primary outcome will be differences in nutrition intake between the groups. Secondary outcomes will be: the amount of unplanned tube discontinuations; handgrip and patients' quality of life, nausea \& vomiting.

The study will include 40 patients at Aarhus University Hospital, Denmark.

Conditions

  • Malnutrition
  • Liver Diseases, Alcoholic

Interventions

DEVICE

Gastric tube (Nutricia Flocare® Pur Tube Enlock)

Nutricia Flocare® Pur Tube Enlock, Ch. 12

DEVICE

Jejunal tube (Nutricia Flocare® Bengmark®)

Nutricia Flocare® Bengmark®, Ch. 10

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Palle Bager, PhD · Aarhus University Hospital, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02319252 on ClinicalTrials.gov